On 2025-05-13, IGM Biosciences, Inc. (IGMS) announced earnings per share of $-0.86 for the fiscal quarter ending 2025-03-31, missing the average analyst estimate of $-0.41.
The next expected annoucement date for quarterly earnings is 2025-08-13, with an average estimated earnings per share of $-0.48 for the fiscal quarter ending 2025-06-30.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2025-05-13 | 2025-03-31 | $-0.41 | $-0.86 |
| 2025-03-06 | 2024-12-31 | $-0.72 | $-0.61 |
| 2024-11-08 | 2024-09-30 | $-0.82 | $-1.01 |
| 2024-08-14 | 2024-06-30 | $0.18 | $-0.79 |
| 2024-05-08 | 2024-03-31 | $-0.84 | $-0.83 |
| 2024-03-07 | 2023-12-31 | $-1.06 | $-1.01 |
| 2023-11-13 | 2023-09-30 | $-1.25 | $-1.04 |
| 2023-08-03 | 2023-06-30 | $-1.43 | $-1.43 |
| 2023-05-12 | 2023-03-31 | $-1.37 | $-1.33 |
| 2023-03-30 | 2022-12-31 | $-1.53 | $-1.19 |
| 2022-11-03 | 2022-09-30 | $-1.45 | $-1.32 |
| 2022-08-08 | 2022-06-30 | $-1.44 | $-1.33 |
| 2022-05-09 | 2022-03-31 | $-1.65 | $-1.53 |
| 2022-03-29 | 2021-12-31 | $-1.58 | $-1.50 |
| 2021-11-04 | 2021-09-30 | $-1.34 | $-1.32 |
| 2021-08-09 | 2021-06-30 | $-1.21 | $-1.16 |
| 2021-05-06 | 2021-03-31 | $-0.98 | $-0.95 |
| 2021-03-30 | 2020-12-31 | $-0.74 | $-0.79 |
| 2020-11-05 | 2020-09-30 | $-0.69 | $-0.66 |
| 2020-08-06 | 2020-06-30 | $-0.65 | $-0.62 |
| 2020-05-07 | 2020-03-31 | $-0.56 | $-0.58 |
| 2020-03-26 | 2019-12-31 | $-0.44 | $-0.49 |
| 2019-11-07 | 2019-09-30 | $-1.09 | $-2.41 |